• Service
  • Resources
    • Webinars
    • Upcoming Events
    • Documents Download
    • FAQ
    • NMPA Approval Report
  • News
  • CER
  • About
Subscribe

Our Services

Strategy Consulting

  • Market Entry Strategy
  • Regulatory Strategy
  • Clinical Strategy
  • China Localization Strategy
  • Hainan Urgent Use Pathway
  • Innovation Pathway
  • Fast Track Pathway
  • Digital Health Consulting

Registration Affairs

  • Pre-market Registration
  • Modification Registration
  • Renewal Registration
  • Request for Classification
  • Legal Agent Representation
  • NMPA Expert Panel Meeting
  • NMPA Supplemental Notice

Quality Assurance

  • Postmarket Surveillance Compliance (IFU, Label, GSP)
  • Adverse Event Reporting
  • Recall Handling
  • Periodic Risk Evaluation Report
  • Annual QMS Self-Inspection Report
  • NMPA Inspections & Mock-Audit
  • QMS Establishment/Audit/Remediation
  • QA Gap Analysis
  • Factory Audit
  • Unique Device Identifier

Device Testing

  • China Local Type Testing
  • Device Modification Compliance Testing
  • Biocompatibility Testing
  • EMC Testing

Clinical Research Organization (CRO)

  • Clinical Trials/Research
  • Real-World Study
  • China CER & MDR CER
  • Clinical Evaluation Feasibility Assessment

Customized Training

  • China Regulatory Training
  • China QMS Training
  • China GCP Training
  • China Localization Training
  • Periodic Regulatory Updates Training

Other Services

  • Translation
  • Patent & Trademark
  • Distributor Evaluation & Audit
  • KOL Interview/Consultation
  • Investment
  • Global regulatory services
  • Service
  • Resources
    • Resources
    • Webinars
    • Upcoming Events
    • Documents Download
    • FAQ
    • NMPA Approval Report
  • News
  • About
  • CER
  • Subscribe
  • CN
  • US
  • Home
  • News
  • Other News

News


  • Moments
  • Regulations & Guidelines
  • Fast Track Update
  • QMS/PMS
  • Other News
  • NMPA Monthly Newsletter
  • 2025
  • 2024
  • 2023
  • 2022
  • 2021

BradyKnows Medical Named Top 10 CRO In APAC 2022

2022-12-16

BradyKnows Medical is honored to be named Top 10 CRO in APAC 2022 by Pharma Tech Outlook magazine.…

Seize Golden Chance To Facilitate Your Market Access To China: Shanghai Launched Several Favorable Measures For Overseas MedTech Companies

2022-12-02

In order to support the development of biomedical R&D economy, Shanghai Municipal Drug Administration issued a number of…

China NMPA Newsletter – October 2022

2022-11-30

Featured Articles NMPA New Approvals In October 2022 In October 2022, NMPA approved 204 medical devices, including 34…

NMPA Notice On Medical Sodium Hyaluronate Product Category

2022-11-23

With the rapid development of science and technology and industry, new products continue to emerge. The NMPA issued…

NMPA Medical Device Classification Catalogue Updating

2022-11-22

According to the Working Procedure for Dynamic Adjustment of the Medical Device Classification Catalogue and related requirements, the …

The Third Batch Of Medical Device Product Classification Identification In 2022

2022-11-22

Center for Medical Device Standardization Administration, a branch of NMPA, issued a summary of the third batch of…

NMPA Notice On Adjustment Of Technical Consultation About Medical Devices Registration Before Application Acceptance

2022-11-22

In order to comprehensively promote the development of China’s medical device industry and give full play to the…

NMPA New Approvals In October 2022

2022-11-16

In October 2022, NMPA approved 204 medical devices, including 34 Class III imported products, 23 Class II imported…

First Approval Of ENT Active Implant In China With Hainan Real World Data

2022-11-04

NMPA first approved the ENT active implants in June and July, 2022 with a clinical evaluation report (CER)…

China NMPA Newsletter – September 2022

2022-10-31

Featured Articles NMPA New Approvals In September 2022 In September 2022, NMPA approved 222 medical devices, including 24…

NMPA New Approvals In September 2022

2022-10-31

In September 2022, NMPA approved 222 medical devices, including 24 Class III imported products, 33 Class II imported…

Last Call For Testing & Modification Registration Of The GB 9706.1-2020 Standard Upgrade!

2022-10-27

If your active medical device was approved by the China NMPA before 2021, most likely, you are not…
« Prev...24...7891011...141618...Next »
Twitter Linkedin
United States
Email: info@bradyknowsmedical.com
Phone: +86 18600392020
China
Beijing Office: Room 1501-1502, East Ocean Centre, No. 24 A, Jianguomenwai Avenue, Chaoyang District, Beijing, China
Shanghai Office: Lingang New Zone, China (Shanghai) Pilot Free Trade Zone
Hainan Office: Boao Lecheng pilot zone of international medical tourism, Qionghai City, Hainan Province
Email: info@bradyknowsmedical.com
Phone: +86 18600392020 +86 10 65155991

©2025 Bradynuoen Beijing PharmTech Co Ltd All Rights Reserved.

京ICP备15042665号-7